Synthesis and pharmacological evaluations of novel conjugates of steroidal-antedrugs and non-steroidal anti-inflammatory drugs

Medicinal Chemistry Research

Volumn 11, Issue 5, 2002, Pages 255-277

  McLean, Hugh M ^a   Heiman, Ann S ^b   Lee, Henry J ^b  

^a HAMPTON UNIVERSITY   (United States)

^b FLORIDA A AND M UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA,21 DIHYDROXY 3,20 DIOXOPREGNA 1,4 DIENE 16ALPHA CARBOXYLATE; 4 DIMETHYLAMINOPYRIDINE; 9ALPHA FLUOROMETHYL 11BETA,21 DIHYDROXY 3,20 DIOXOPREGNA 1,4 DIENE 16ALPHA CARBOXYLATE; CARBOXYLIC ACID DERIVATIVE; CORTICOSTERONE; COTRIMOXAZOLE; CROTON OIL; CYTARABINE; DEXAMETHASONE; DICYCLOHEXYLCARBODIIMIDE; FLUOROURACIL DERIVATIVE; IBUPRED; IBUPROFEN; INDOMETACIN; INDOPRED; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE; PREDNISOLONE ACETATE; STEROID; UNCLASSIFIED DRUG;

ADRENAL GLAND; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BINDING AFFINITY; BODY WEIGHT; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DOSE RESPONSE; DRUG ANTAGONISM; DRUG CONJUGATION; DRUG CYTOTOXICITY; DRUG POTENCY; DRUG POTENTIATION; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; EDEMA; LIVER CELL CARCINOMA; MALE; NONHUMAN; ORGAN WEIGHT; PARTITION COEFFICIENT; RAT; STRUCTURE ACTIVITY RELATION; THYMUS; TIME SERIES ANALYSIS; TUMOR CELL LINE;

EID: 0036976204     PISSN: 10542523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Hench, P.S., Kendall, E.C., Slocum, C.H., Polley, H.F. Effect of hormone of adrenal cortex (17-hydroxy-11-dehydrocorticosterone; Compound E) and of pituitary adrenocorticotropic hormone on rheumatoid arthritis; preliminary report. Proc. Staff. Meet. Mayo Clin., 1949, 24, 181.
2. Green, M.J., and Lutsky, B.N. Anti-inflammatory steroids. In Handbook of Cardiovascular and Anti-inflammatory agents., Verderame, M. (Ed.); CRC Press, Boca Raton, FL. 1986.
3. Kehrl, J.H., Fauci, A.S. The clinical use of glucocorticoids. Annals of Allergy. 1983, 50, 1, 2-10.
4. Nelson, A.M., Conn, D.L. Series on Pharmacology in Practice: glucocorticoids in rheumatic diseases. Mayo Clin. Proc., 1980, 55, 758.
5. Thorn, G.W. Clinical considerations in the use of corticosteroids. N. Engl. J. Med., 1966, 274, 775.
6. David, D.S., Grieco, M.H. and Cushman, P. Adrenal glucocorticoids after twenty years. A review of their clinically relevant consequences. J. Chron. Dis. 1970, 22, 637.
7. Lee, H.J., You, J., Ko, D.H., and Yoon, K.J. New steroidal anti-inflammatory agents: Prednisolone derivatives with an isoxazoline fusion at the 16 and 17-carbons and an alkyl carboxylate at the 16Α-position. Drugs Exptl. Clin. Res., 1998, 24(2): 57-66.
8. Khalil, M.A., Kwon, T., and Lee, H.J. A novel approach to the development of safer anti-inflammatory steroids: Antedrugs, Current Topics in Med. Chem., 1993, 1: 173-202.
9. Avery, M.A., Woolfrey, J.R. Anti-inflammatory steroids. In Wolff, M.E. (Ed), Medicinal Chemistry and Drug Discovery. John Wiley & Sons, Inc. 281-376, 1997.
10. Timofeevski, S.L., Panarin, E.F., Vinogradov, O.L., and Nezhentsev, M.V. Anti-inflammatory and antishock water soluble polyesters of glucocorticoids with low level systemic toxicity. Pharm. Res., 1996, 13(3): 476-480.
11. Szelfer, S.J. A review of budesonide inhalation suspension in the treatment of pediatric asthma. Pharmacotherapy, 2001, 21(2): 195-206.
12. Martin-du Pan, R.C., Vonlanthen, M.C., and Dubuis, J.M. Growth and collagen synthesis disorders in asthmatic children treated with inhaled steroids. Rev. Med. Suisse Romande, 1999, 119(6): 475-479.
13. Lipworth, B.J. Systemic adverse effects of inhaled corticosteroid therapy: A systematic review and meta-analysis. Arch. Intern. Med., 1999, 159(9):941-955.
14. Geddes, D.M. Inhaled corticosteroids: benefits and risks. Thorax, 1992, 47: 404-407.
15. Portner, M., Mollmann, H.J., and Rohdewald, P. Glucocorticoid receptors in synovial tissue and relative receptor affinities of glucocorticoid-21-esters. Pharmaceutical Research, 1988, 5, 10, 623-627.
16. McLean, H.M. (1991). Ph.D. Thesis in: Synthesis and Pharmacological Evaluation of Novel Conjugates of Glucocorticoids and Non-Steroidal Anti-inflammatory Agents. College of Pharmacy, Florida A&M University, Tallahassee, FL 32307.
17. Gip, L. and Hamfelt, A. Studies on the efficacy and adrenal effects of diprolene ointment 0.05 percent and dermovate ointment 0.05 percent in patients with psoriasis or other resistant dermatoses. Cutis, 1984, 33(2): 215-217.
18. Li, J.T., Goldstein, M.F., Gross, G.N., Noonan, M.J., Weisberg, S., Edwards, L., Reed, K.D., and Rogenes, P.R. Effects of fluticasone propionate, triamcinolone acetonide, prednisone, and placebo on the hypothalmic-pituitary-adrenal axis. J. Allergy Clin. Immunol., 1999, 103(4): 622-629.
19. Stanbury, R.M. and Graham, E.M. Systemic corticosteroid therapy-side effects and their management. Br. J. Ophthalmol., 1998, 82(6): 704-708.
20. Chrousos, G.P. and Harris, A.G. Hypothalmic-pituitary-adrenal axis suppression and inhaled corticosteroid therapy. 1. General principles. Neuroimmunomodulation, 1998, 5(6): 277-287.
21. Li, J.T., Ford, L.B., Chervinsky, P., Weisberg, S.C., Kellerman, D.J., Faulkner, K.G., Herje, N.E., Hamedani, A., Harding, S.M. and Shah, T. Fluticasone propionate powder and lack of clinically significant effects on hypothalmic-pituitary-adrenal axis and bone mineral density over 2 years in adults with mild asthma. J. Allergy Clin. Immunol., 1999, 103(6): 1062-1068.
22. Kuna, P. Longterm effects of steroid therapy. Wiad. Lek., 1998, 51 suppl. I: 12-18.
23. Martin-du Pan, R.C., Volanthen, M.C., Dubuis, J.M. Growth and collagen synthesis disorders in asthmatic children treated with inhaled steroids. Rev. Med. Suisse Romande, 1999, 119(6): 475-479.
24. Grassi, W., De Angelis, R. and Cervini, C. Corticosteroid prescribing in rheumatoid arthritis and psoriatic arthritis. Clin. Rheumatology, 1998, 17(3): 223-226.
25. Maibach, H.J. Topical corticoid therapy. Part 1. Adverse effects of topical corticosteroids. Systemic Cutis, 1979, 24, 446-448.
26. Vestergaard, L. and Andersen, K.E. Contact allergy to local steroids. Contact allergy to corticoisteroids among consecutively tested patients with eczema. Ugeskr. Laeger, 1997, 159(38): 5662-5666.
27. Akkoca, O., Mungan, D., Karabiyikoglu, G. and Misirligil, Z. Inhaled and systemic corticosteroid therapies. Do they contribute to inspiratory muscle weakness in asthma? Respiration, 1999, 66(4): 332-337.
28. Dasgupta, B., Dolan, A.L., Panayi, G.S. and Fernandes, L. An initially double-blind controlled 96 week trial of depot methylprednisolone against oral prednisolone in the treatment of polymyalgia rheumatica. Br. Rheumatol., 1998, 37(2): 189-195.
29. Jeffcoate, W. Assessment of corticosteroid replacement therapy in adults with adrenal insufficiency. Ann. Clin. Biochem., 1999, 36 (part 2): 151-157.
30. Hamano, K., Ohta, A., Masamura, K., Hashiguchi, N., Takekuma, A., Ushiyama, O., Suzuki, N., Inoue, E., Inoue, N. and Nagasawa, K. Relationship between the experience of steroids side effects and noncompliance with oral steroids treatment in collagen disease patients. Kango Kenkyu, 1997, 30(6): 47-54.
31. Lee, H.J. and Soliman, M.R.I. Anti-inflammatory steroids without pituitary adrenal suppression. Science, 1982, 215: 989-991.
32. Heiman, A.S., Taraporewala, I.B., McLean, H.M., Hong, D. and Lee, H.J. New potent topical anti-inflammatory steroids with reduced side effects: derivatives of steroid-16-carboxy esters. J. Pharm. Sci. 1990, 79, 7, 617-621.
33. Popper, T.L. and Watnick, A.S. Anti-inflammatory steroids. In Anti-inflammatory Agents (Scherer, R.A., and Whitehouse, M.W., Eds), Vol. 1, pp. 245-294. Academic Press, New York, New York, 1974.
34. Phillips, G.H. Locally active corticosteroids: structure-activity relationships. In Mechanism of Tropical Corticosteroid Activity (Wilson, L., and Marks, R., Eds), pp. 1-18. Livingstone, Edingburgh, U.K., 1976.
35. Elks, J. Steroid structure and steroid activity. Br. J. Dermatol.: 1976, 94, Suppl. 12, 2-13.
36. Munck, A., and Leung, K. Glucocorticoid receptors and mechanisms of action. In Receptors and Mechanism of Action Steroid Hormones (Pasqualini, J.R., Ed.), pp. 311-397, part 2. Mercel Dekker, New York, New York, 1977.
37. Wolff, M.E. Structure-activity relationship in glucocorticoids. In Glucocorticoid Hormone Action (Baxter, J.D., and Rousseau, G.G., Eds) pp. 97-107. Springer, Berlin, Germany, 1979.
38. Myles, G.E., Stafford, R.O., Lyster, S.E., and Bowman, B.J. Relation between biological activity of hydrocortisone analogues and their rates of inactivation by rat liver enzyme studies. Endocrinology 1957, 61, 128-142.
39. Ballard, P.L. Delivery and transport of glucocorticoids to target cells. In glucocorticoid Hormone Action (Baxter, J.D., and Rousseau, G.G., Eds.), pp. 25-48. Springer, Berlin, Germany, 1979.
40. Lee, H.J., You, Z., Ko, D. H., and McLean, H. M. Recent advances in prodrugs and antedrugs. Current Opinion in Drug Discovery & Development, 1998, 1 (2): 235-244.
41. McLean, H.M., and Lee, H.J. Synthesis and pharmacological evaluation of conjugates of prednisolone and non-steroidal anti-inflammatory agents. Steroids, 1989, 54: 421-439.
42. Menger, F.M., and Rourk, M.J. Synthesis and reactivity of 5-fluorouracil/cytarabine mutual prodrugs. J. Org. Chem., 1997, 62: 9083-9088.
43. Lutsky, B.N., Berkenkopf, J., Fernandez, X., Monahan, M., and Watnick, A.S. Selective effects of 7 alpha-halogeno substitution on corticosteroid activity: Sch. 22219 and Sch. 23409. Arzneimittel Forschung, 1979, 29: 992-998.
44. McLean, H.M., Khalil, M.A., Heisman, A.S., and Lee, H.J. Novel fluorinated anti-inflammatory steroid with reduced side effects: Methyl 9α-fluoroprednisolone-16-carboxylate. J. Pharm. Sci., 1994, 83, 4, 476-480
45. Neises, B., and Steglich, W. Simple method for the esterification of carboxylic acids. ANGEW INT EDIT, 1978, 17: 522-524.
46. Brewster, M.E., Deyrup, M., Czako, K., Bodor, N. Extension of a redox-based chemical delivery system to α, β-unsaturated ketones. J. Med. Chem. 1990, 30, 8, 2063-2065.
47. Lowry, O.H., Rosebrough, N.J., Farr, A.L., and Randall, R.L. Protein Measurement with Folin Phenol reagent. J. Biol. Chem., 1951, 193: 265-275.
48. Ponec, M., Kempenaar, J., Shroot, B., and Caron, J.C. Glucocorticoids: Binding affinity and lipophilicity. J. Pharm. Sci. 1986, 75, 973-975.
49. Mizushima, Y., Igarashi, R., Hoshi, K., Muramatsu, M. and Fujita, A. Increase in incorporation into lymphocytes in vitro of esterified anti-inflammatory corticosteroids. Agents and Actions 1986, 19(1/2), 123-126.
50. Muramatsu, M., Fujita, A., Tanaka, M., Ishii, Y., Aihara, H. Enhancement of affinity to receptors in the esterified glucocorticoid, hydrocortisone 17-butyrate 21-propionate (HBP), in rat liver. Biochem. Pharmacol., 1986, 35, 1933-1937.
51. Alhaider, A.A., Sellassie, C.D., Chua, S., Lien, E.J. Measurements of ionization constants and partition coefficients of guanazole prodrugs. J. Pharm. Sci. 1982, 71, 89-94.
52. Dearden, J.C., Bresnen, G.M. The measurement of partition coefficiems. Quant. Struct. act. Rel. 1998, 17, 133-144.
53. Al-Habet, S.M.H., Lee, H.J. In vitro hydrolysis of steroid acid ester derivatives of prednisolone in plasma of different species. J. Pharm. Sci. 1990, 79, 10, 916-918.